Top Markets
Coin of the day
Catalent, Inc. Catalent, Inc.

Catalent, Inc.

CTLT
Classificação em ações #1926
Catalent, Inc., operating globally through its various subsidiaries,... Catalent, Inc., operating globally through its various subsidiaries, specializes in the development and production of comprehensive solutions for a wide array of products, including pharmaceutical drugs, protein-based biologics, advanced cell and gene therapies, and consumer health items. The company's operations are strategically divided into four key segments: Biologics; Softgel and Oral Technologies; Oral and Specialty Delivery; and Clinical Supply Services. The Softgel and Oral Technologies division focuses on the formulation, development, and manufacturing of soft capsules. These are utilized in a diverse range of client products, such as prescription medications, over-the-counter drugs, nutritional supplements, unit-dose cosmetics, and medicinal preparations for animal health. Within the Biologics segment, Catalent undertakes the creation of biologic cell lines, develops and manufactures both cell therapy and viral-based gene therapy, and handles the formulation and production of parenteral dose forms, including vials, prefilled syringes, and cartridges. This segment also provides essential analytical development and testing capabilities. The Oral and Specialty Delivery segment offers extensive formulation, development, and manufacturing expertise across various technologies. It provides integrated downstream solutions spanning clinical development and commercial supply. This segment also features a dedicated oral delivery solutions platform, encompassing preclinical screening, formulation, analytical development, and current good manufacturing practices (cGMP) services. Finally, the Clinical Supply Services segment delivers vital support for drug and biologic clinical trials. Its services include manufacturing, specialized packaging, secure storage, efficient distribution, and comprehensive inventory management. This segment also offers "FastChain," a demand-led clinical supply service. Catalent serves a broad client base, including pharmaceutical, biotechnology, and consumer health organizations, alongside companies in other healthcare sectors like animal health and medical devices, and even the cosmetics industry. The company was founded in 2007 and maintains its headquarters in Somerset, New Jersey.
Preço da ação
$63.48
Última sincronização: 2024-12-17
Valor de mercado
$11.52B
Variação (1 dia)
0.00%
Variação (1 ano)
0.00%
País
US
Negociar Catalent, Inc. (CTLT)

Categoria

Preço CTLT com a capitalização de mercado de B
Catalent, Inc. Catalent, Inc.
CTLT
$63.48
Capitalização de mercado de Catalent, Inc.(CTLT)
Valor de mercado: $11.52B
Em August 2026, Catalent, Inc. tem uma capitalização de mercado de $11.52B. Isso faz com que Catalent, Inc. seja a 1926th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de Catalent, Inc. de 2014 a 2026
CTLT comparado com o topo de 5 mais populares stocks
Preço para CTLT Ativo B Capitalização de mercado de B Resultados
Catalent, Inc. Catalent, Inc.
$27,838.96 $11.52B
$5.053T +43,754.70%
Catalent, Inc. Catalent, Inc.
$25,146.49 $11.52B
$4.564T +39,513.25%
Catalent, Inc. Catalent, Inc.
$23,114.19 $11.52B
$4.196T +36,311.77%
Catalent, Inc. Catalent, Inc.
$19,993.66 $11.52B
$3.629T +31,396.00%
Catalent, Inc. Catalent, Inc.
$15,543.14 $11.52B
$2.821T +24,385.09%